Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1995 1
1996 2
1997 1
1998 4
1999 4
2000 7
2001 8
2002 12
2003 10
2004 10
2005 12
2006 15
2007 10
2008 8
2009 4
2010 4
2011 9
2012 8
2013 6
2014 6
2015 6
2016 7
2017 11
2018 6
2019 10
2020 7
2021 7
2022 9
2023 12
2024 14
2025 9
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

228 results

Results by year

Filters applied: . Clear all
Page 1
Chronic Pruritus: A Review.
Butler DC, Berger T, Elmariah S, Kim B, Chisolm S, Kwatra SG, Mollanazar N, Yosipovitch G. Butler DC, et al. JAMA. 2024 Jun 25;331(24):2114-2124. doi: 10.1001/jama.2024.4899. JAMA. 2024. PMID: 38809527 Review.
First-line treatment for inflammatory chronic pruritus includes topical anti-inflammatory therapies such as hydrocortisone (2.5%), triamcinolone (0.1%), or tacrolimus ointment. ...When no underlying systemic disease associated with pruritus is identified, patients a …
First-line treatment for inflammatory chronic pruritus includes topical anti-inflammatory therapies such as hydrocortisone (2.5%), tr …
Topical tacrolimus Protopic.
Lazarous MC, Kerdel FA. Lazarous MC, et al. Drugs Today (Barc). 2002 Jan;38(1):7-15. Drugs Today (Barc). 2002. PMID: 12532181 Review.
Topical tacrolimus is the first topical immunomodulator of its kind, and its mechanism of action, pharmacokinetics, metabolism and efficacy will be discussed. ...Although oral administration of tacrolimus proved to be efficacious in psoriasis, r
Topical tacrolimus is the first topical immunomodulator of its kind, and its mechanism of action, pharmacokinetics, met
Topical tacrolimus in dermatology.
Nasr IS. Nasr IS. Clin Exp Dermatol. 2000 May;25(3):250-4. doi: 10.1046/j.1365-2230.2000.00628.x. Clin Exp Dermatol. 2000. PMID: 10844509 Review.
They have been used topically in various clinical studies. Topical cyclosporin A is largely ineffective whereas topical tacrolimus is effective in treating atopic dermatitis. Topical tacrolimus has not been studied sufficiently in treatin …
They have been used topically in various clinical studies. Topical cyclosporin A is largely ineffective whereas topical
Drugs for psoriasis.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2019 Jun 17;61(1574):89-96. Med Lett Drugs Ther. 2019. PMID: 31381544 Review. No abstract available.
[Inverse psoriasis].
Weisenseel P, Reich K. Weisenseel P, et al. Hautarzt. 2015 Jun;66(6):408-12. doi: 10.1007/s00105-015-3628-7. Hautarzt. 2015. PMID: 25896586 Review. German.
Inverse psoriasis is clinically defined by chronic inflammatory lesions in intertrigineous areas. ...Controlled clinical studies are only available for topical ascomycin....
Inverse psoriasis is clinically defined by chronic inflammatory lesions in intertrigineous areas. ...Controlled clinical studies are …
Tacrolimus in dermatology.
Dé Tran QH, Guay E, Chartier S, Tousignant J. Dé Tran QH, et al. J Cutan Med Surg. 2001 Jul-Aug;5(4):329-35. doi: 10.1007/s102270000022. Epub 2001 May 2. J Cutan Med Surg. 2001. PMID: 11907845 Review.
In human, small studies have reported tacrolimus ointment to be effective in controlling acute contact dermatitis. Short-term trials of topical tacrolimus in the treatment of atopic dermatitis have recently shown excellent results in both adults and children. …
In human, small studies have reported tacrolimus ointment to be effective in controlling acute contact dermatitis. Short-term trials …
Psoriasis and pregnancy.
Tauscher AE, Fleischer AB Jr, Phelps KC, Feldman SR. Tauscher AE, et al. J Cutan Med Surg. 2002 Nov-Dec;6(6):561-70. doi: 10.1007/s10227-001-0147-1. Epub 2002 Oct 9. J Cutan Med Surg. 2002. PMID: 12362257 Review.
CONCLUSION: Topical corticosteroids and topical calcipotriene as well as topical anthralin and topical tacrolimus appear to be safe choices for control of localized psoriasis in pregnancy. UVB is the safest treatment for extensive psor
CONCLUSION: Topical corticosteroids and topical calcipotriene as well as topical anthralin and topical tacrol
Assigning new roles to topical tacrolimus.
Rallis E, Korfitis C, Gregoriou S, Rigopoulos D. Rallis E, et al. Expert Opin Investig Drugs. 2007 Aug;16(8):1267-76. doi: 10.1517/13543784.16.8.1267. Expert Opin Investig Drugs. 2007. PMID: 17685874 Review.
Tacrolimus in its topical formulation has been established as a safe and effective alternative to topical corticosteroids because of its mild side effects and its minimal systemic absorption. Topical tacrolimus has been approved for the treatmen
Tacrolimus in its topical formulation has been established as a safe and effective alternative to topical corticosteroi
Treatments for inverse psoriasis: a systematic review.
Reynolds KA, Pithadia DJ, Lee EB, Wu JJ. Reynolds KA, et al. J Dermatolog Treat. 2020 Dec;31(8):786-793. doi: 10.1080/09546634.2019.1620912. Epub 2019 May 31. J Dermatolog Treat. 2020. PMID: 31100992 Free article.
These studies comprised over 1000 patients with mild to severe psoriasis involving axillary, inframammary, facial, and/or anogenital regions. The included studies demonstrated efficacy of topical immunomodulators (N = 7), vitamin D analogs (N = 4), topical co …
These studies comprised over 1000 patients with mild to severe psoriasis involving axillary, inframammary, facial, and/or anogenital …
Pimecrolimus: a review.
Gupta AK, Chow M. Gupta AK, et al. J Eur Acad Dermatol Venereol. 2003 Sep;17(5):493-503. doi: 10.1046/j.1468-3083.2003.00692.x. J Eur Acad Dermatol Venereol. 2003. PMID: 12941081 Review.
As well, the effectiveness of pimecrolimus 0.6% cream was comparable to 0.1% betamethasone-17-valerate; however, pimecrolimus was not associated with any of the side effects characteristic of a topical steroid. Topical application of pimecrolimus is not associated w …
As well, the effectiveness of pimecrolimus 0.6% cream was comparable to 0.1% betamethasone-17-valerate; however, pimecrolimus was not associ …
228 results